Moderna CEO on Earnings, Flu Shots and Skin Cancer Trials
•Moderna’s first-quarter sales beat expectations, as the struggling vaccine maker that’s faced resistance from the Trump administration has found new growth outside the US.
•Moderna CEO Stephane Bancel sits down with Bloomberg's Katie Greifeld, saying the company's skin cancer trial results should arrive this year.
هذا الخبر من Bloomberg. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.
Moderna’s first-quarter sales beat expectations, as the struggling vaccine maker that’s faced resistance from the Trump administration has found new growth outside the US. Moderna CEO Stephane Bancel sits down with Bloomberg's Katie Greifeld, saying the company's skin cancer trial results should arrive this year. (Source: Bloomberg)المصدر: Bloomberg | Source: Bloomberg
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Bloomberg. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Bloomberg. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
